The truncated isoform of somatostatin receptor5 (sst5TMD4) is associated with poorly differentiated thyroid cancer.
Somatostatin receptors (ssts) are expressed in thyroid cancer cells, but their biological significance is not well understood. The aim of this study was to assess ssts in well differentiated (WDTC) and poorly differentiated thyroid cancer (PDTC) by means of imaging and molecular tools and its relati...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2014
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/c720d5555a354221b8e584d4004b00a5 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:c720d5555a354221b8e584d4004b00a5 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:c720d5555a354221b8e584d4004b00a52021-11-18T08:37:01ZThe truncated isoform of somatostatin receptor5 (sst5TMD4) is associated with poorly differentiated thyroid cancer.1932-620310.1371/journal.pone.0085527https://doaj.org/article/c720d5555a354221b8e584d4004b00a52014-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24465589/?tool=EBIhttps://doaj.org/toc/1932-6203Somatostatin receptors (ssts) are expressed in thyroid cancer cells, but their biological significance is not well understood. The aim of this study was to assess ssts in well differentiated (WDTC) and poorly differentiated thyroid cancer (PDTC) by means of imaging and molecular tools and its relationship with the efficacy of somatostatin analog treatment. Thirty-nine cases of thyroid carcinoma were evaluated (20 PDTC and 19 WDTC). Depreotide scintigraphy and mRNA levels of sst-subtypes, including the truncated variant sst5TMD4, were carried out. Depreotide scans were positive in the recurrent tumor in the neck in 6 of 11 (54%) PDTC, and in those with lung metastases in 5/11 cases (45.4%); sst5TMD4 was present in 18/20 (90%) of PDTC, being the most densely expressed sst-subtype, with a 20-fold increase in relation to sst2. In WDTC, sst2 was the most represented, while sst5TMD4 was not found; sst2 was significantly increased in PDTC in comparison to WDTC. Five depreotide positive PDTC received octreotide for 3-6 months in a pilot study with no changes in the size of the lesions in 3 of them, and a significant increase in the pulmonary and cervical lesions in the other 2. All PDTC patients treated with octreotide showed high expression of sst5TMD4. ROC curve analysis demonstrated that only sst5TMD4 discriminates between PDTC and WDTC. We conclude that sst5TMD4 is overexpressed in PDTC and may be involved in the lack of response to somatostatin analogue treatment.Manel Puig-DomingoRaúl M LuqueJordi L ReverterLaura M López-SánchezManuel D GaheteMichael D CullerGonzalo Díaz-SotoFrancisco LomeñaMattia SquarciaJosé Luis MateMireia MoraLaureano Fernández-CruzOscar VidalAntonio AlastruéJose BalibreaIrene HalperinDídac MauricioJusto P CastañoPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 9, Iss 1, p e85527 (2014) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Manel Puig-Domingo Raúl M Luque Jordi L Reverter Laura M López-Sánchez Manuel D Gahete Michael D Culler Gonzalo Díaz-Soto Francisco Lomeña Mattia Squarcia José Luis Mate Mireia Mora Laureano Fernández-Cruz Oscar Vidal Antonio Alastrué Jose Balibrea Irene Halperin Dídac Mauricio Justo P Castaño The truncated isoform of somatostatin receptor5 (sst5TMD4) is associated with poorly differentiated thyroid cancer. |
| description |
Somatostatin receptors (ssts) are expressed in thyroid cancer cells, but their biological significance is not well understood. The aim of this study was to assess ssts in well differentiated (WDTC) and poorly differentiated thyroid cancer (PDTC) by means of imaging and molecular tools and its relationship with the efficacy of somatostatin analog treatment. Thirty-nine cases of thyroid carcinoma were evaluated (20 PDTC and 19 WDTC). Depreotide scintigraphy and mRNA levels of sst-subtypes, including the truncated variant sst5TMD4, were carried out. Depreotide scans were positive in the recurrent tumor in the neck in 6 of 11 (54%) PDTC, and in those with lung metastases in 5/11 cases (45.4%); sst5TMD4 was present in 18/20 (90%) of PDTC, being the most densely expressed sst-subtype, with a 20-fold increase in relation to sst2. In WDTC, sst2 was the most represented, while sst5TMD4 was not found; sst2 was significantly increased in PDTC in comparison to WDTC. Five depreotide positive PDTC received octreotide for 3-6 months in a pilot study with no changes in the size of the lesions in 3 of them, and a significant increase in the pulmonary and cervical lesions in the other 2. All PDTC patients treated with octreotide showed high expression of sst5TMD4. ROC curve analysis demonstrated that only sst5TMD4 discriminates between PDTC and WDTC. We conclude that sst5TMD4 is overexpressed in PDTC and may be involved in the lack of response to somatostatin analogue treatment. |
| format |
article |
| author |
Manel Puig-Domingo Raúl M Luque Jordi L Reverter Laura M López-Sánchez Manuel D Gahete Michael D Culler Gonzalo Díaz-Soto Francisco Lomeña Mattia Squarcia José Luis Mate Mireia Mora Laureano Fernández-Cruz Oscar Vidal Antonio Alastrué Jose Balibrea Irene Halperin Dídac Mauricio Justo P Castaño |
| author_facet |
Manel Puig-Domingo Raúl M Luque Jordi L Reverter Laura M López-Sánchez Manuel D Gahete Michael D Culler Gonzalo Díaz-Soto Francisco Lomeña Mattia Squarcia José Luis Mate Mireia Mora Laureano Fernández-Cruz Oscar Vidal Antonio Alastrué Jose Balibrea Irene Halperin Dídac Mauricio Justo P Castaño |
| author_sort |
Manel Puig-Domingo |
| title |
The truncated isoform of somatostatin receptor5 (sst5TMD4) is associated with poorly differentiated thyroid cancer. |
| title_short |
The truncated isoform of somatostatin receptor5 (sst5TMD4) is associated with poorly differentiated thyroid cancer. |
| title_full |
The truncated isoform of somatostatin receptor5 (sst5TMD4) is associated with poorly differentiated thyroid cancer. |
| title_fullStr |
The truncated isoform of somatostatin receptor5 (sst5TMD4) is associated with poorly differentiated thyroid cancer. |
| title_full_unstemmed |
The truncated isoform of somatostatin receptor5 (sst5TMD4) is associated with poorly differentiated thyroid cancer. |
| title_sort |
truncated isoform of somatostatin receptor5 (sst5tmd4) is associated with poorly differentiated thyroid cancer. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2014 |
| url |
https://doaj.org/article/c720d5555a354221b8e584d4004b00a5 |
| work_keys_str_mv |
AT manelpuigdomingo thetruncatedisoformofsomatostatinreceptor5sst5tmd4isassociatedwithpoorlydifferentiatedthyroidcancer AT raulmluque thetruncatedisoformofsomatostatinreceptor5sst5tmd4isassociatedwithpoorlydifferentiatedthyroidcancer AT jordilreverter thetruncatedisoformofsomatostatinreceptor5sst5tmd4isassociatedwithpoorlydifferentiatedthyroidcancer AT lauramlopezsanchez thetruncatedisoformofsomatostatinreceptor5sst5tmd4isassociatedwithpoorlydifferentiatedthyroidcancer AT manueldgahete thetruncatedisoformofsomatostatinreceptor5sst5tmd4isassociatedwithpoorlydifferentiatedthyroidcancer AT michaeldculler thetruncatedisoformofsomatostatinreceptor5sst5tmd4isassociatedwithpoorlydifferentiatedthyroidcancer AT gonzalodiazsoto thetruncatedisoformofsomatostatinreceptor5sst5tmd4isassociatedwithpoorlydifferentiatedthyroidcancer AT franciscolomena thetruncatedisoformofsomatostatinreceptor5sst5tmd4isassociatedwithpoorlydifferentiatedthyroidcancer AT mattiasquarcia thetruncatedisoformofsomatostatinreceptor5sst5tmd4isassociatedwithpoorlydifferentiatedthyroidcancer AT joseluismate thetruncatedisoformofsomatostatinreceptor5sst5tmd4isassociatedwithpoorlydifferentiatedthyroidcancer AT mireiamora thetruncatedisoformofsomatostatinreceptor5sst5tmd4isassociatedwithpoorlydifferentiatedthyroidcancer AT laureanofernandezcruz thetruncatedisoformofsomatostatinreceptor5sst5tmd4isassociatedwithpoorlydifferentiatedthyroidcancer AT oscarvidal thetruncatedisoformofsomatostatinreceptor5sst5tmd4isassociatedwithpoorlydifferentiatedthyroidcancer AT antonioalastrue thetruncatedisoformofsomatostatinreceptor5sst5tmd4isassociatedwithpoorlydifferentiatedthyroidcancer AT josebalibrea thetruncatedisoformofsomatostatinreceptor5sst5tmd4isassociatedwithpoorlydifferentiatedthyroidcancer AT irenehalperin thetruncatedisoformofsomatostatinreceptor5sst5tmd4isassociatedwithpoorlydifferentiatedthyroidcancer AT didacmauricio thetruncatedisoformofsomatostatinreceptor5sst5tmd4isassociatedwithpoorlydifferentiatedthyroidcancer AT justopcastano thetruncatedisoformofsomatostatinreceptor5sst5tmd4isassociatedwithpoorlydifferentiatedthyroidcancer AT manelpuigdomingo truncatedisoformofsomatostatinreceptor5sst5tmd4isassociatedwithpoorlydifferentiatedthyroidcancer AT raulmluque truncatedisoformofsomatostatinreceptor5sst5tmd4isassociatedwithpoorlydifferentiatedthyroidcancer AT jordilreverter truncatedisoformofsomatostatinreceptor5sst5tmd4isassociatedwithpoorlydifferentiatedthyroidcancer AT lauramlopezsanchez truncatedisoformofsomatostatinreceptor5sst5tmd4isassociatedwithpoorlydifferentiatedthyroidcancer AT manueldgahete truncatedisoformofsomatostatinreceptor5sst5tmd4isassociatedwithpoorlydifferentiatedthyroidcancer AT michaeldculler truncatedisoformofsomatostatinreceptor5sst5tmd4isassociatedwithpoorlydifferentiatedthyroidcancer AT gonzalodiazsoto truncatedisoformofsomatostatinreceptor5sst5tmd4isassociatedwithpoorlydifferentiatedthyroidcancer AT franciscolomena truncatedisoformofsomatostatinreceptor5sst5tmd4isassociatedwithpoorlydifferentiatedthyroidcancer AT mattiasquarcia truncatedisoformofsomatostatinreceptor5sst5tmd4isassociatedwithpoorlydifferentiatedthyroidcancer AT joseluismate truncatedisoformofsomatostatinreceptor5sst5tmd4isassociatedwithpoorlydifferentiatedthyroidcancer AT mireiamora truncatedisoformofsomatostatinreceptor5sst5tmd4isassociatedwithpoorlydifferentiatedthyroidcancer AT laureanofernandezcruz truncatedisoformofsomatostatinreceptor5sst5tmd4isassociatedwithpoorlydifferentiatedthyroidcancer AT oscarvidal truncatedisoformofsomatostatinreceptor5sst5tmd4isassociatedwithpoorlydifferentiatedthyroidcancer AT antonioalastrue truncatedisoformofsomatostatinreceptor5sst5tmd4isassociatedwithpoorlydifferentiatedthyroidcancer AT josebalibrea truncatedisoformofsomatostatinreceptor5sst5tmd4isassociatedwithpoorlydifferentiatedthyroidcancer AT irenehalperin truncatedisoformofsomatostatinreceptor5sst5tmd4isassociatedwithpoorlydifferentiatedthyroidcancer AT didacmauricio truncatedisoformofsomatostatinreceptor5sst5tmd4isassociatedwithpoorlydifferentiatedthyroidcancer AT justopcastano truncatedisoformofsomatostatinreceptor5sst5tmd4isassociatedwithpoorlydifferentiatedthyroidcancer |
| _version_ |
1718421586808143872 |